정밀 종양학 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 기술별, 암 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Precision Oncology Market size was valued at USD 120.0 Billion in 2024 and is poised to grow from USD 131.4 Billion in 2025 to USD 271.59 Billion by 2033, growing at a CAGR of 9.5% during the forecast period (2026-2033).

The precision oncology market is primarily driven by the integration of high-throughput genomic technologies and targeted therapies, creating a direct connection between molecular diagnostics and treatment strategies. This approach tailors cancer care to individual tumor biology, enhancing response rates and minimizing toxicity. The shift from single-gene tests to comprehensive next-generation sequencing panels, coupled with liquid biopsies, exemplifies the market's evolution. Growth is further supported by the integration of data across genomics, clinical records, and real-world evidence, facilitating the discovery of rare targets and efficient trial matching. Advances in reimbursement for next-generation sequencing and the increased use of liquid biopsies for patient monitoring attract investment in AI-driven decision support, ultimately expanding market access and creating scalable pathways in diverse regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Oncology Market Segments Analysis

Global precision oncology market is segmented by product, technology, cancer type, application, end-user and region. Based on product, the market is segmented into Diagnostics, Therapeutics, Data Analytics & Software and Others. Based on technology, the market is segmented into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Microarray and Others. Based on cancer type, the market is segmented into Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancers and Others. Based on application, the market is segmented into Diagnostics, Drug Development & Clinical Trials, Personalized Treatment Selection, Prognostics and Others. Based on end-user, the market is segmented into Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies and Research & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Oncology Market

The Global Precision Oncology market is significantly driven by advancements in genomic profiling technologies that enhance the identification of tumor-specific molecular signatures. This progress facilitates more accurate patient stratification and selection of targeted therapies, increasing clinical confidence in personalized treatment options. As diagnostic assays become more comprehensive and biomarker interpretation improves, the perceived value of precision oncology rises among stakeholders, leading to increased investment in diagnostic platforms and companion tests. This trend not only bolsters the expansion of service offerings but also promotes the integration of precision oncology into standard care practices, further solidifying its role in modern healthcare.

Restraints in the Global Precision Oncology Market

The Global Precision Oncology market faces significant challenges due to the high costs linked to advanced genomic assays and the need for specialized laboratory facilities. Additionally, the ongoing investment required in bioinformatics and skilled labor can restrict the adoption of these technologies, particularly in settings with limited budgets. Elevated per-test costs and uncertainties surrounding reimbursement further diminish the motivation for routine adoption, causing healthcare providers to favor traditional diagnostic methods. This financial strain on laboratories and healthcare institutions may hinder the growth of testing services and disrupt the integration of precision oncology into standard clinical practices, ultimately restricting market expansion and accessibility.

Market Trends of the Global Precision Oncology Market

The Global Precision Oncology market is witnessing a significant trend towards comprehensive multi-omics integration, where the convergence of genomic, transcriptomic, proteomic, and metabolomic data is transforming traditional diagnostic approaches. This holistic perspective enables enhanced patient stratification and more precise therapeutic matching, moving away from reliance on single-marker diagnostics. The establishment of cross-platform assays and expansive laboratory networks is fostering richer biomarker discovery, while aligned data standards and interoperable pipelines are improving clinical decision-making. As stakeholders-including diagnostics developers, pharmaceutical companies, and clinical centers-collaborate more closely, integrated services and value-based models are emerging, creating new opportunities in precision oncology across the globe.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Precision Oncology Market Size by Product & CAGR (2026-2033)

• Market Overview
• Diagnostics
• Therapeutics
• Data Analytics & Software
• Others

Global Precision Oncology Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• In Situ Hybridization (ISH)
• Immunohistochemistry (IHC)
• Microarray
• Others

Global Precision Oncology Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Blood Cancers
• Others

Global Precision Oncology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostics
• Drug Development & Clinical Trials
• Personalized Treatment Selection
• Prognostics
• Others

Global Precision Oncology Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research & Academic Institutes

Global Precision Oncology Market Size & CAGR (2026-2033)

• North America (Product, Technology, Cancer Type, Application, End-User)
  • US
  • Canada
• Europe (Product, Technology, Cancer Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Cancer Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Cancer Type, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Cancer Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foundation Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caris Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations